1. Legionella pneumophilamacrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding
- Author
-
C. Wiedemann, J.J. Whittaker, V.H. Pérez Carrillo, B. Goretzki, M. Dajka, F. Tebbe, J.-M. Harder, P. Krajczy, B. Joseph, F. Hausch, A. Guskov, and U.A. Hellmich
- Abstract
Macrophage infectivity potentiator (MIP) proteins are widespread in human pathogens includingLegionella pneumophila, the causative agent of Legionnaires’ disease and protozoans such asTrypanosoma cruzi. All MIP proteins contain a FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain that hence presents an attractive drug target. Some MIPs such as theLegionellaprotein (LpMIP) have additional appendage domains of mostly unknown function. In full-length, homodimericLpMIP, the N-terminal dimerization domain is linked to the FKBP-like domain via a long, free-standing stalk helix. Combining X-ray crystallography, NMR and EPR spectroscopy and SAXS, we elucidated the importance of the stalk helix for protein dynamics and inhibitor binding to the FKBP-like domain and bidirectional crosstalk between the different protein regions. The first comparison of a microbial MIP and a human FKBP in complex with the same synthetic inhibitor was made possible by high-resolution structures ofLpMIP with a [4.3.1]-aza-bicyclic sulfonamide and provides a basis for designing pathogen-selective inhibitors. Through stereospecific methylation, the affinity of inhibitors to toL. pneumophilaandT. cruziMIP was greatly improved. The resulting X-ray inhibitor-complex structures ofLpMIP and TcMIP at 1.49 and 1.34 Å, respectively, provide a starting point for developing potent inhibitors against MIPs from multiple pathogenic microorganisms.
- Published
- 2023
- Full Text
- View/download PDF